Full Text View
Tabular View
No Study Results Posted
Related Studies
Nasogastric Tube in Premature Babies - Pain and Treatment
This study has been completed.

First Received on September 20, 2005.   Last Updated on February 2, 2009   History of Changes
Sponsor: Norwegian University of Science and Technology
Collaborator: St. Olavs Hospital
Information provided by: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT00218946
  Purpose

Does sucrose or pacifier influence pain in premature babies when a nasogastric tube is inserted?


Condition Intervention Phase
Infant, Premature
Drug: Sucrose
Device: Pacifier
Phase II

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Single Blind (Caregiver)
Official Title: Nasogastric Tube in Premature Babies - Pain and Treatment. A Randomised, Partly Blinded, Placebo-Controlled Factorial Clinical Trial of Sucrose and Pacifier

Resource links provided by NLM:


Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • Pain measured on PIPP (Premature Infant Pain Profile) scale [ Time Frame: 4 week to complete ] [ Designated as safety issue: No ]

Enrollment: 24
Study Start Date: January 2005
Study Completion Date: August 2007
Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: 1
no fluid, no pacifier
Drug: Sucrose
fluids: 30 % sucrose or sterile water Pacifier: yes or no
Device: Pacifier
Yes or no
Experimental: 2
water, no pacifier
Drug: Sucrose
fluids: 30 % sucrose or sterile water Pacifier: yes or no
Device: Pacifier
Yes or no
Experimental: 3
Sucrose, no pacifier
Drug: Sucrose
fluids: 30 % sucrose or sterile water Pacifier: yes or no
Device: Pacifier
Yes or no
Experimental: 4
No fluid, pacifier
Drug: Sucrose
fluids: 30 % sucrose or sterile water Pacifier: yes or no
Device: Pacifier
Yes or no
Experimental: 5
water, pacifier
Drug: Sucrose
fluids: 30 % sucrose or sterile water Pacifier: yes or no
Device: Pacifier
Yes or no
Experimental: 6
sucrose, pacifier
Drug: Sucrose
fluids: 30 % sucrose or sterile water Pacifier: yes or no
Device: Pacifier
Yes or no

Detailed Description:

A total of 24 premature babies are randomised to receive either placebo (sterile water), 30 % sucrose, or pacifier in a complete factorial, cross-over design. Pain is rated on the PIPP scale by observers blinded to the procedure other than use of pacifier.

  Eligibility

Ages Eligible for Study:   up to 8 Weeks
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 28 - 32 weeks gestational weeks
  • not on mechanical ventilation

Exclusion Criteria:

  • high risk group regarding cerebral prognosis
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00218946

Locations
Norway
St. Olavs University Hospital
Trondheim, Norway, N-7006
Sponsors and Collaborators
Norwegian University of Science and Technology
St. Olavs Hospital
Investigators
Study Director: Eirik Skogvoll, MD, PhD Norwegian University of Science and Technology
  More Information

Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Eirik Skogvoll, MD PhD, Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT00218946     History of Changes
Other Study ID Numbers: NISE-2005-1
Study First Received: September 20, 2005
Last Updated: February 2, 2009
Health Authority: Norway: Norwegian Social Science Data Services

Keywords provided by Norwegian University of Science and Technology:
pain,premature,nasogastric tube,PIPP

ClinicalTrials.gov processed this record on February 12, 2012